Policy Leaders

Reduce Complexity and Scale Transformative Change

ATI’s experts bring industry-leading data capabilities and deep understanding of healthcare policy and practice to deliver market-transforming insights and ideas. ATI develops innovations to improve care, backed by data and centered on the patient.

Together with public and private leaders, we ask the questions, explore the data, and design new policy approaches.

Our Services

ATI Services for Policy Leaders

Strategy & Policy

  • Healthcare financing and delivery system redesign (federal, state, local)
  • Reimbursement and payment policy transformation
  • Model design and development

Research & Analytics

  • Population characteristics
  • Health disparities and approaches to improving equity
  • Access and outcomes
  • Market and product insights
  • Stakeholder engagement and insights

Innovation

  • Training, technical assistance, and learning collaboratives for continuous improvement
  • Evidence and policy development for new pharmaceutical products
  • Outcomes-based contract implementation and support (federal, state)

Evidence & Evaluation

  • Evaluations of intervention strategies
  • Performance and ROI assessments

By the Numbers

33M
33.1M people <400% FPL and not eligible for Medicaid
15%
Medicare Advantage enrollment has increased 15% in two years
ER utilization and Medicare AB spending is correlated significantly with income in the Traditional Medicare Population
7%
With 7% of Medicare Advantage beneficiaries churning in and out of plans each year, policymakers must understand beneficiary needs, preferences, and experiences to design programs to meet needs
The number of individuals who are 65+ who are projected to use formal, paid services is expected to grow from 7.4M to 14.4M in 2065
80
By 2023, there will be 80 drugs selected for Medicare negotiation
$20B
Spending on gene therapies more than $20B per year

Research + Resources for Policy Leaders

Contact Us

Email us at info@atiadvisory.com or fill out the form below and we’ll be in touch.